We are live on ! Find out more
AMED

Amedisys
AMED

Delisted

AMED was delisted on the 14th of August, 2025.

Back to rankings

4 hedge funds and large institutions have $57.6K invested in Amedisys in 2025 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 315 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 319 → 4 (-315)

99.1% less ownership

Funds ownership: 99.1% → 0% (-99%)

99% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 315

100% less funds holding in top 10

Funds holding in top 10: 6 → 0 (-6)

100% less capital invested

Capital invested by funds: $3.2B → $57.6K (-$3.2B)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
4
Holders Change
-315
Holders Change %
-98.75%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-100%
% of All Funds
–
New
2
Increased
–
Reduced
2
Closed
315
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
IA
IFP Advisors
Florida
+$7.08K
2
MCI
MRP Capital Investments
Georgia
+$2.46K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$329M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$299M
3
PCM
Pentwater Capital Management
Florida
-$169M
4
Fidelity International
Fidelity International
Bermuda
-$129M
5
AAM
Alpine Associates Management
Florida
-$108M
Name Holding Trade Value Shares
Change 		Change in
Stake
CA
276
Clearstead Advisors
Ohio
– -$7.87K -80 Closed
AW
277
Avion Wealth
Texas
– -$7K -76 Closed
NEWAS
278
N.E.W. Advisory Services
Wisconsin
– -$6.2K -63 Closed
FFA
279
Farther Finance Advisors
California
– -$5.8K -59 Closed
SAM
280
Smartleaf Asset Management
Massachusetts
– -$5.68K -58 Closed
CAL
281
Capital Advisors Ltd
Ohio
– -$6K -56 Closed
GWM
282
Geneos Wealth Management
Colorado
– -$5.51K -56 Closed
PFBT
283
Parkside Financial Bank & Trust
Missouri
– -$5.12K -52 Closed
Mitsubishi UFJ Asset Management
284
Mitsubishi UFJ Asset Management
Japan
– -$4.92K -50 Closed
SIS
285
Sound Income Strategies
Florida
– -$3.84K -39 Closed
CPG
286
Cornerstone Planning Group
New Jersey
– -$3.67K -37 Closed
PWMG
287
Prestige Wealth Management Group
New Jersey
– -$3.64K -37 Closed
KG
288
Kilter Group
New York
– -$2.85K -29 Closed
TWD
289
True Wealth Design
Ohio
– -$2.85K -29 Closed
EP
290
Essential Partners
California
– -$2.56K -26 Closed
GRP
291
Global Retirement Partners
California
– -$2.56K -26 Closed
HFS
292
Hughes Financial Services
Virginia
– -$2.58K -26 Closed
FMII
293
Farmers & Merchants Investments Inc
Nebraska
– -$2.46K -25 Closed
PS
294
Principal Securities
Iowa
– -$2.46K -25 Closed
RTL
295
Red Tortoise LLC
Georgia
– -$2.26K -23 Closed
AssetMark Inc
296
AssetMark Inc
California
– -$2.17K -22 Closed
FFO
297
Fortitude Family Office
Arizona
– -$2.17K -22 Closed
BBHC
298
Brown Brothers Harriman & Co
New York
– -$2.07K -21 Closed
LFG
299
Larson Financial Group
Missouri
– -$2.07K -21 Closed
PWA
300
Physician Wealth Advisors
Utah
– -$1.97K -20 Closed
9 10 11
12
13

AMED Hedge Fund Activity: Q3 2025 in Review

4 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q3 2025, worth a combined $57.6K — down 100% from $3.2B a quarter earlier.

Sellers outnumbered buyers: 315 funds closed out of AMED and 2 opened new positions — a net loss of 313 holders — while 2 trimmed existing stakes and 0 added.

The largest buyer was IFP Advisors, opening a new position worth an estimated $7.08K. The largest seller was BlackRock, exiting entirely with an estimated $329M sold.

  • 4 institutional investors held Amedisys (AMED) as of Q3 2025, down from 319 in Q2 2025.
  • Funds reported $57.6K of Amedisys stock for Q3 2025, down 100% quarter-over-quarter.
  • 2 funds opened new Amedisys positions in Q3 2025 and 315 closed out, a net change of -313 holders.
  • The largest Amedisys buyer in Q3 2025 was IFP Advisors, an estimated $7.08K added.
  • The largest Amedisys seller in Q3 2025 was BlackRock, an estimated $329M sold.

Based on aggregated 13F filings for Q3 2025.